Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146

Breast Cancer Research and Treatment

Volumn 127, Issue 1, 2011, Pages 33-41

  Mostert, Bianca ^a,b   Kraan, Jaco ^a   Bolt De Vries, Joan ^b   Van Der Spoel, Petra ^a   Sieuwerts, Anieta M ^b   Schutte, Mieke ^b   Timmermans, Annemieke M ^b   Foekens, Renée ^b   Martens, John W M ^b   Gratama, Jan Willem ^a   Foekens, John A ^b   Sleijfer, Stefan ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Breast cancer; CD146; CellSearch; Circulating tumor cells; EpCAM; Minimal residual disease

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKERATIN; EPITHELIAL CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL COUNT; CIRCULATING CANCER CELL; CONTROLLED STUDY; CYTOCHEMISTRY; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD146; ANTIGENS, CD34; BREAST NEOPLASMS; CELL LINE, TUMOR; DIAGNOSTIC TECHNIQUES AND PROCEDURES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79954689654     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0879-y     Document Type: Article

References (31)

1. S Sleijfer JW Gratama AM Sieuwerts J Kraan JW Martens JA Foekens 2007 Circulating tumour cell detection on its way to routine diagnostic implementation? Eur J Cancer 43 18 2645 2650 17977713 1:CAS:528: DC%2BD2sXhsVSgs7nM (Pubitemid 350151847)
2. B Mostert S Sleijfer JA Foekens JW Gratama 2009 Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer Cancer Treat Rev 35 5 463 474 19410375 10.1016/j.ctrv.2009.03.004 1:CAS:528: DC%2BD1MXptlSks70%3D
3. M Cristofanilli GT Budd MJ Ellis A Stopeck J Matera MC Miller JM Reuben GV Doyle WJ Allard LW Terstappen, et al. 2004 Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 8 781 791 15317891 10.1056/NEJMoa040766 1:CAS:528:DC%2BD2cXntVeitb4%3D (Pubitemid 39095313)
4. M Cristofanilli DF Hayes GT Budd MJ Ellis A Stopeck JM Reuben GV Doyle J Matera WJ Allard MC Miller, et al. 2005 Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 23 7 1420 1430 15735118 10.1200/JCO.2005.08.140
5. SmerageJB HD 2008 The prognostic implications of circulating tumor cells in patients with breast cancer Cancer Invest 26 2 109 114 10.1080/ 07357900701784204 (Pubitemid 351225457)
6. Rack BK, Schindlbeck C, Schneeweiss A, Hilfrich J, Lorenz R, Beckmann MW, Pantel K, Lichtenegger W, Sommer HL, Janni WL (2008) Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: the German SUCCESS-Trial. J Clin Oncol 26 (May 20 suppl: abstr 503)
7. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen, et al. 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
8. AM Sieuwerts J Kraan J Bolt P van der Spoel F Elstrodt M Schutte JW Martens JW Gratama S Sleijfer JA Foekens 2009 Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells J Natl Cancer Inst 101 1 61 66 19116383 1:CAS:528:DC%2BD1MXltFSltQ%3D%3D
9. M Smid Y Wang Y Zhang AM Sieuwerts J Yu JG Klijn JA Foekens JW Martens 2008 Subtypes of breast cancer show preferential site of relapse Cancer Res 68 9 3108 3114 18451135 10.1158/0008-5472.CAN-07-5644 1:CAS:528:DC%2BD1cXltlSmt7Y%3D
10. AM Sieuwerts J Kraan J Bolt P van der Spoel F Elstrodt M Smid M Timmermans B Mostert M Schutte JW Martens, et al. 2009 Response: Re: anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells J Natl Cancer Inst 101 12 896 897 10.1093/jnci/djp118
11. G Spizzo P Went S Dirnhofer P Obrist R Simon H Spichtin R Maurer U Metzger B von Castelberg R Bart, et al. 2004 High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer Breast Cancer Res Treat 86 3 207 213 15567937 10.1023/B:BREA.0000036787.59816.01 1:CAS:528:DC%2BD2cXmt1Kqt74%3D (Pubitemid 39070963)
12. G Zabouo AM Imbert J Jacquemier P Finetti T Moreau B Esterni D Birnbaum F Bertucci C Chabannon 2009 CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines Breast Cancer Res 11 1 1 10.1186/bcr2215
13. F Elstrodt A Hollestelle JH Nagel M Gorin M Wasielewski A van den Ouweland SD Merajver SP Ethier M Schutte 2006 BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants Cancer Res 66 1 41 45 16397213 10.1158/0008-5472.CAN-05-2853 1:CAS:528: DC%2BD28XhsFWmtw%3D%3D (Pubitemid 43166006)
14. Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M, Ng SS, French PJ, Peeters JK, Rozendaal MJ et al (2009) Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat (Epub ahead of print)
15. MH Strijbos JW Gratama J Kraan CH Lamers MA den Bakker S Sleijfer 2008 Circulating endothelial cells in oncology: pitfalls and promises Br J Cancer 98 11 1731 1735 18506173 10.1038/sj.bjc.6604383 1:CAS:528:DC%2BD1cXmtlCisL4%3D (Pubitemid 351748848)
16. RH Brakenhoff JG Stroomer C ten Brink R de Bree SM Weima GB Snow GA van Dongen 1999 Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction Clin Cancer Res 5 4 725 732 10213205 1:CAS:528:DyaK1MXislOns7Y%3D (Pubitemid 29180821)
17. L Fina HV Molgaard D Robertson NJ Bradley P Monaghan D Delia DR Sutherland MA Baker MF Greaves 1990 Expression of the CD34 gene in vascular endothelial cells Blood 75 12 2417 2426 1693532 1:CAS:528:DyaK3cXkslKisr4%3D (Pubitemid 20202322)
18. DT Ross U Scherf MB Eisen CM Perou C Rees P Spellman V Iyer SS Jeffrey M Van de Rijn M Waltham, et al. 2000 Systematic variation in gene expression patterns in human cancer cell lines Nat Genet 24 3 227 235 10700174 10.1038/73432 1:CAS:528:DC%2BD3cXhvFaqtrg%3D (Pubitemid 30132189)
19. JM Rae CJ Creighton JM Meck BR Haddad MD Johnson 2007 MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research Breast Cancer Res Treat 104 1 13 19 17004106 10.1007/s10549-006-9392-8 (Pubitemid 46976633)
20. AF Chambers 2009 MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69 13 5292 5293 19549886 10.1158/0008-5472.CAN-09-1528 1:CAS:528:DC%2BD1MXnvFWqurg%3D
21. JL Rowand G Martin GV Doyle MC Miller MS Pierce MC Connelly C Rao LW Terstappen 2007 Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas Cytometry A 71 2 105 113 17226859 (Pubitemid 46238939)
22. WF Pickl O Majdic GF Fischer P Petzelbauer I Fae M Waclavicek J Stockl C Scheinecker T Vidicki H Aschauer, et al. 1997 MUC18/MCAM (CD146), an activation antigen of human T lymphocytes J Immunol 158 5 2107 2115 9036955 1:CAS:528:DyaK2sXhtlGmsb4%3D (Pubitemid 127469992)
23. DA Smirnov BW Foulk GV Doyle MC Connelly LW Terstappen SM O'Hara 2006 Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas Cancer Res 66 6 2918 2922 16540638 10.1158/0008-5472.CAN-05-4003 1:CAS:528:DC%2BD28Xitlers7Y%3D
24. SAGE anatomic viewer: KRT18 expression in vascular tissue. http://cgap.nci.nih.gov/SAGE/AnatomicViewer
25. DF Hayes M Cristofanilli GT Budd MJ Ellis A Stopeck MC Miller J Matera WJ Allard GV Doyle LW Terstappen 2006 Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival Clin Cancer Res 12 14 Pt 1 4218 4224 16857794 10.1158/1078-0432.CCR-05-2821 1:CAS:528:DC%2BD28XntFSms7Y%3D
26. GT Budd M Cristofanilli MJ Ellis A Stopeck E Borden MC Miller J Matera M Repollet GV Doyle LW Terstappen, et al. 2006 Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer Clin Cancer Res 12 21 6403 6409 17085652 10.1158/1078-0432.CCR-05-1769 1:CAS:528: DC%2BD28XhtFKitb%2FJ (Pubitemid 44799711)
27. JY Pierga FC Bidard C Mathiot E Brain S Delaloge S Giachetti P de Cremoux R Salmon A Vincent-Salomon M Marty 2008 Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial Clin Cancer Res 14 21 7004 7010 18980996 10.1158/1078-0432.CCR-08-0030 1:CAS:528:DC%2BD1cXhtlens7bL
28. N Bardin F George M Mutin C Brisson N Horschowski V Frances G Lesaule J Sampol 1996 S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen Tissue antigens 48 5 531 539 8988535 10.1111/j.1399-0039.1996.tb02666.x 1:CAS:528:DyaK2sXisVahtw%3D%3D (Pubitemid 27007292)
29. Lehmann JM, Riethmuller G, Johnson JP (1989) MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86(24):9891-9895 (Pubitemid 20030740)
30. MF Elshal SS Khan N Raghavachari Y Takahashi J Barb JJ Bailey PJ Munson MA Solomon RL Danner JP McCoy Jr 2007 A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile BMC Immunol 8 29 17999761 10.1186/1471-2172-8-29 (Pubitemid 351682236)
31. N Despoix T Walzer N Jouve M Blot-Chabaud N Bardin P Paul L Lyonnet E Vivier F Dignat-George F Vely 2008 Mouse CD146/MCAM is a marker of natural killer cell maturation Eur J Immunol 38 10 2855 2864 18958886 10.1002/eji.200838469 1:CAS:528:DC%2BD1cXhtlOjsL7L